TMCnet News
Downgrade Alert for Endo Pharmaceuticals (ENDP)May 09, 2013 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- Endo Pharmaceuticals (NASDAQ:ENDP) was downgraded from Buy to Neutral at Buckingham today. The stock closed yesterday at $38.21 on volume of 2.2 million shares, below average daily volume of 2.5 million. Endo Pharmaceuticals (NASDAQ:ENDP) is currently priced 10.3% above its average consensus analyst price target of $33.08. The stock should discover initial support at its 50-day moving average (MA) of $33.40 and subsequent support at its 200-day MA of $30.46. Endo Pharmaceuticals share prices have moved between a 52-week high of $44.53 and a 52-week low of $25.00 and closed yesterday at 47% above that low price at $36.87 per share. The 200-day and 50-day moving averages have moved 0.33% higher and 1.51% higher over the past week, respectively. Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, develops, produces, and markets both branded and generic pharmaceuticals. Endo's products include Percocet, Percodan, and Lidoderm. SmarTrend recommended that subscribers consider buying shares of Endo Pharmaceuticals on January 24th, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $28.23. Since that recommendation, shares of Endo Pharmaceuticals have risen 30.6%. We continue to monitor ENDP for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |